Literature DB >> 11699045

Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.

Y Hamada1, H Ikegami, H Ueda, Y Kawaguchi, E Yamato, K Nojima, K Yamada, N Babaya, M Shibata, T Ogihara.   

Abstract

To clarify the mechanisms of impaired insulin secretion in Nagoya-Shibata-Yasuda (NSY) mice, an inbred strain of mice with spontaneous development of type 2 (non-insulin-dependent) diabetes mellitus, the insulin response to glucose (5.5 to 27.8 mmol/L) and nonglucose stimuli (glibenclamide, arginine, and BayK8644, a Ca-channel opener) was studied in vitro using isolated islets from male NSY and control C3H/He mice at 36 weeks of age by the batch incubation method. Insulin response to 5.5 mmol/L glucose was not significantly different between NSY and C3H/He mice, but insulin response to a high concentration of glucose (> or = 11.1 mmol/L) was significantly smaller in NSY mice than in control C3H/He mice. The dose-response curve of insulin secretion showed a markedly reduced maximum response, but almost normal glucose sensitivity in NSY islets. Insulin responses to glibenclamide (1 mmol/L), arginine (20 mmol/L), and BayK8644 (0.1 mmol/L) were also significantly smaller in NSY mice than in C3H/He mice. Insulin content of islets, in contrast, was significantly higher in NSY mice than in C3H/He mice. The impaired insulin response to glucose and nonglucose stimuli together with higher insulin content in islets in the NSY mouse suggest that a defect in voltage-dependent Ca(2+)-channel or thereafter in the cascade of insulin secretion may be responsible for impaired insulin secretion in NSY mice. NSY mice, therefore, could be a novel animal model of type 2 diabetes with a defect in insulin secretion at a different site from that in previously known animal models. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699045     DOI: 10.1053/meta.2001.27198

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Direct evidence for susceptibility genes for type 2 diabetes on mouse chromosomes 11 and 14.

Authors:  N Babaya; T Fujisawa; K Nojima; M Itoi-Babaya; K Yamaji; K Yamada; M Kobayashi; H Ueda; Y Hiromine; S Noso; H Ikegami
Journal:  Diabetologia       Date:  2010-07       Impact factor: 10.122

2.  Fatty liver and obesity: phenotypically correlated but genetically distinct traits in a mouse model of type 2 diabetes.

Authors:  M Itoi-Babaya; H Ikegami; T Fujisawa; H Ueda; K Nojima; N Babaya; M Kobayashi; S Noso; Y Kawaguchi; K Yamaji; M Shibata; T Ogihara
Journal:  Diabetologia       Date:  2007-06-05       Impact factor: 10.122

3.  Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant.

Authors:  Mototsugu Nagao; Akira Asai; Momoyo Kawahara; Yasushi Nakajima; Yuki Sato; Kyoko Tanimura; Fumitaka Okajima; Makiyo Takaya; Mariko Sudo; Shuji Takemitsu; Taro Harada; Hitoshi Sugihara; Shinichi Oikawa
Journal:  J Diabetes Investig       Date:  2012-06-06       Impact factor: 4.232

4.  Novel murine model of congenital diabetes: The insulin hyposecretion mouse.

Authors:  Kenta Nakano; Rieko Yanobu-Takanashi; Yuki Takahashi; Hayato Sasaki; Yukiko Shimizu; Tadashi Okamura; Nobuya Sasaki
Journal:  J Diabetes Investig       Date:  2018-08-17       Impact factor: 4.232

5.  Cellular biophysical dynamics and ion channel activities detected by AFM-based nanorobotic manipulator in insulinoma β-cells.

Authors:  Ruiguo Yang; Ning Xi; King Wai Chiu Lai; Kevin C Patterson; Hongzhi Chen; Bo Song; Chengeng Qu; Beihua Zhong; Donna H Wang
Journal:  Nanomedicine       Date:  2012-11-22       Impact factor: 5.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.